| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VERASTEM INC | 20,900 | 189,000 | 0.03% | ||
| 2 | UNIQURE NV | 21,466 | 292,000 | 0.04% | ||
| 3 | RAPTOR PHARMACEUTICAL CORP | 40,400 | 467,000 | 0.06% | ||
| 4 | Sunesis Pharmaceuticals I | 91,800 | 599,000 | 0.08% | ||
| 5 | TELEFLEX INC | 5,800 | 612,000 | 0.08% | ||
| 6 | AEGERION PHARMACEUTICALS INC | 20,000 | 642,000 | 0.09% | ||
| 7 | MEDIDATA SOLUTIONS INC | 18,900 | 809,000 | 0.11% | ||
| 8 | XOMA CORP DEL | 177,200 | 813,000 | 0.11% | ||
| 9 | AMBIT BIOSCIENCES CORP | 151,100 | 1,044,000 | 0.14% | ||
| 10 | Arrowhead Pharma Inc | 80,000 | 1,145,000 | 0.16% | ||
| 11 | PACIRA PHARMACEUTICALS INC | 13,300 | 1,222,000 | 0.17% | ||
| 12 | ONCOMED PHARMACEUTICALS INC COM | 52,800 | 1,230,000 | 0.17% | ||
| 13 | TG THERAPEUTICS INC COM | 135,000 | 1,268,000 | 0.17% | ||
| 14 | MEI PHARMA INC | 201,600 | 1,278,000 | 0.17% | ||
| 15 | FEI COMPANY | 14,800 | 1,343,000 | 0.18% | ||
| 16 | ATHENA HEALTH INC. | 11,100 | 1,389,000 | 0.19% | ||
| 17 | KARYOPHARM THERAPEUTICS INC COM | 30,000 | 1,397,000 | 0.19% | ||
| 18 | VERSARTIS INC | 50,000 | 1,402,000 | 0.19% | ||
| 19 | ACELRX PHARMACEUTICALS INC | 139,400 | 1,429,000 | 0.19% | ||
| 20 | NEUROCRINE BIOSCIE COM USD0.001 | 96,600 | 1,434,000 | 0.20% | ||
| 21 | DICERNA PHARMACEUTICALS INC | 63,700 | 1,438,000 | 0.20% | ||
| 22 | CARDIOVASCULAR SYS INC DEL COM | 52,700 | 1,642,000 | 0.22% | ||
| 23 | CEMPRA INC | 153,800 | 1,650,000 | 0.22% | ||
| 24 | INSMED INC | 88,600 | 1,770,000 | 0.24% | ||
| 25 | INCONTACT INC | 193,300 | 1,776,000 | 0.24% | ||
| 26 | BRUKER CORP | 73,900 | 1,794,000 | 0.24% | ||
| 27 | BIOMARIN PHARMACEUTICAL INC | 30,200 | 1,879,000 | 0.26% | ||
| 28 | NATUS MEDICAL INC. | 75,000 | 1,886,000 | 0.26% | ||
| 29 | HYPERION THERAPEUTICS INC | 76,300 | 1,991,000 | 0.27% | ||
| 30 | CERNER CORP | 38,900 | 2,006,000 | 0.27% | ||
| 31 | CUBIST PHARMACEUTI | 29,000 | 2,025,000 | 0.28% | ||
| 32 | ACCELERON PHARMA INC | 62,100 | 2,110,000 | 0.29% | ||
| 33 | REPLIGEN CORP COM | 99,400 | 2,265,000 | 0.31% | ||
| 34 | ULTRAGENYX PHARMACEUTICAL INC COM | 52,600 | 2,361,000 | 0.32% | ||
| 35 | SUPERNUS PHARMACEUTICALS INC | 240,600 | 2,635,000 | 0.36% | ||
| 36 | VERACYTE INC | 154,700 | 2,648,000 | 0.36% | ||
| 37 | GW PHARMACEUTICALS PLC | 25,000 | 2,682,000 | 0.36% | ||
| 38 | SALIX PHARMACEUTICALS INC | 21,800 | 2,689,000 | 0.37% | ||
| 39 | ATRICURE INC | 152,300 | 2,799,000 | 0.38% | ||
| 40 | BLUEBIRD BIO INC COM | 76,900 | 2,966,000 | 0.40% | ||
| 41 | MACROGENICS INC | 164,800 | 3,581,000 | 0.49% | ||
| 42 | COGNEX CORP | 100,000 | 3,840,000 | 0.52% | ||
| 43 | TETRAPHASE PHARMACEUTICALS INC COM | 300,900 | 4,059,000 | 0.55% | ||
| 44 | SOLAZYME INC | 384,400 | 4,528,000 | 0.62% | ||
| 45 | AKEBIA THERAPEUTICS INC | 166,200 | 4,619,000 | 0.63% | ||
| 46 | CELLDEX THERAPEUTICS INC NEW | 288,700 | 4,712,000 | 0.64% | ||
| 47 | APPLIED GENETIC TECHNOL CORP | 205,500 | 4,747,000 | 0.65% | ||
| 48 | NEWLINK GENETICS CORP COM | 215,700 | 5,727,000 | 0.78% | ||
| 49 | ASPEN TECHNOLOGY COM USD0.10 | 128,500 | 5,962,000 | 0.81% | ||
| 50 | SOLARCITY CORP | 89,000 | 6,283,000 | 0.85% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-14-000005, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
